Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03973268
Title field or adapter rule
{'original_value': "The Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression", 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:37.146475+00:00
Published At
2026-10-30T00:00:00+00:00
Record Updated At
2026-10-30
Source Retrieved At
2026-10-31T22:19:07.580396+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Depression", "Major Depressive Disorder", "Major Depression"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-30", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT03973268"
protocolSection.identificationModule.officialTitle
"The Mechanism of Action Underlying Ketamine\u0027s Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Depression (protocolSection.conditionsModule.conditions)
  • Major Depressive Disorder (protocolSection.conditionsModule.conditions)
  • Major Depression (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['1', '2', '3'], 'description': 'MagPro 100 TMS Therapy System', 'name': 'Arm 1, 2, 3 device interventions', 'type': 'DEVICE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['2'], 'description': 'Placebo', 'name': 'Arm 2 Interventions', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['1', '2'], 'description': 'Ketamine', 'name': 'Arm 1, 2, 3 drug Interventions', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['1', '2', '3'], 'description': 'Perampanel', 'name': 'Arm 1 and 2 Interventions', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Arm 1, 2, 3 drug Interventions (protocolSection.armsInterventionsModule.interventions[].name)
  • Arm 1 and 2 Interventions (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.